2 mill ion ▁( US $ 2 5 6 mill ion ). ▁▁ 2 0 1 1 – present ▁In ▁ 2 0 1 1 , ▁in ▁a ▁US $ 6 6 0 - mill ion ▁deal , ▁Pr est ige ▁Br ands ▁Hold ings ▁took ▁over ▁ 1 7 ▁G SK ▁br ands ▁with ▁sales ▁of ▁US $ 2 1 0 mill ion , ▁including ▁BC ▁Pow der , ▁Be ano , ▁E cot rin , ▁F iber ▁Cho ice , ▁Go ody ' s ▁Pow der , ▁Som ine x ▁and ▁Tag am et . ▁In ▁ 2 0 1 2 , ▁the ▁company ▁announced ▁that ▁it ▁would ▁invest ▁£ 5 0 0 mill ion ▁in ▁manufact uring ▁facilities ▁in ▁Ul ver ston , ▁northern ▁England , ▁design ating ▁it ▁as ▁the ▁site ▁for ▁a ▁previously ▁announced ▁bi ote ch ▁plant . ▁In ▁May ▁that ▁year ▁it ▁acquired ▁Cell Z ome , ▁a ▁German ▁bi ote ch ▁company , ▁for ▁US $ 9 8 mill ion , ▁and ▁in ▁June ▁world wide ▁rights ▁to ▁al it ret ino in ▁( To ct ino ), ▁an ▁e cz ema ▁drug , ▁for ▁US $ 3 0 2 mill ion . ▁In ▁ 2 0 1 3 , ▁G SK ▁acquired ▁Human ▁Gen ome ▁Sciences ▁( H GS ) ▁for ▁US $ 3 b ill ion ; ▁the ▁companies ▁had ▁collabor ated ▁on ▁developing ▁the ▁l up us ▁drug ▁Bel imum ab ▁( Ben ly sta ), ▁al big l ut ide ▁for